Life Science Compliance Update



Swarming on the Opioid Crisis: Legislative Response Attacks Concerns from All Sides

Written by , Posted in Uncategorized

Katherine Norris

This is the first article in a series exploring the major themes emerging from recent legislative efforts to combat the ‘opioid crisis’ and their potential impact on drug manufacturers’ compliance programs. Currently, there is a myriad of bills before the U.S. Congress attempting to address the growing epidemic of opioid abuse, misuse, and diversion throughout the United States.


  • Return to July 2018 LSC Update Table of Contents
  • Copy abstract URL
  • Order Reprints
  • Topic tags:

    Menu Title